Genenta Science S.p.A.
GNTA
$1.60
-$0.20-11.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.41M | 4.58M | 4.79M | 5.03M | 5.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.46M | 8.38M | 9.38M | 9.89M | 10.56M |
| Operating Income | -7.46M | -8.38M | -9.38M | -9.89M | -10.56M |
| Income Before Tax | -7.34M | -8.36M | -9.46M | -9.46M | -9.64M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.34 | -8.36 | -9.46 | -9.46 | -9.64 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.34M | -8.36M | -9.46M | -9.46M | -9.64M |
| EBIT | -7.46M | -8.38M | -9.38M | -9.89M | -10.56M |
| EBITDA | -7.43M | -8.34M | -9.34M | -9.85M | -10.52M |
| EPS Basic | -0.38 | -0.44 | -0.51 | -0.51 | -0.53 |
| Normalized Basic EPS | -0.23 | -0.28 | -0.32 | -0.32 | -0.33 |
| EPS Diluted | -0.38 | -0.44 | -0.51 | -0.51 | -0.53 |
| Normalized Diluted EPS | -0.23 | -0.28 | -0.32 | -0.32 | -0.33 |
| Average Basic Shares Outstanding | 78.84M | 76.48M | 74.12M | 73.61M | 73.09M |
| Average Diluted Shares Outstanding | 78.84M | 76.48M | 74.12M | 73.61M | 73.09M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |